Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease

Bone Marrow Transplantation

Volumn 30, Issue 3, 2002, Pages 189-194

  Seth, P ^a   Alrajhi, A A ^a   Kagevi, I ^a   Chaudhary, M A ^a   Colcol, E ^a   Sahovic, E ^a   Aljurf, M ^a   Gyger, M ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Cytotoxic T lymphocytes; Graft versus host disease; Hepatitis B core antibody; Hepatitis B virus; Immunosuppression; Reactivation

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; HEPATITIS B CORE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; MEMBRANE ANTIGEN; METHOTREXATE; PREDNISONE; PURINE NUCLEOSIDE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CANCER REGISTRY; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE EXACERBATION; DNA DETERMINATION; DRUG WITHDRAWAL; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING TEST; SEROCONVERSION; SEROLOGY; STATISTICAL ANALYSIS; VIRUS REACTIVATION; ALLOTRANSPLANTATION; BLOOD; GENETICS; GROWTH, DEVELOPMENT AND AGING; MIDDLE AGED; TIME; VIRUS ACTIVATION;

ADOLESCENT; ADULT; CHRONIC DISEASE; DNA, VIRAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 0036669971     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703614     Document Type: Article

References (48)

1. Viral hepatitis, type B
2. The natural history of hepatitis B
3. Hepatitis B virus infection
4. Hepatitis B virus persistence after recovery from acute viral hepatitis
5. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response
6. Persistent viremia after recovery from self-limited acute hepatitis
7. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease
8. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen
9. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases
10. To kill or to cure: Options in host defense against viral infection
11. Perspectives series: Host/pathogen interactions. Cytotoxic T cells and viral hepatitis
12. Protection or damage; a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?
13. How can the cellular immune response control hepatitis B virus replication?
14. Long-lasting memory T cell responses following self-limited acute hepatitis B
15. Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy
16. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
17. Reactivation of hepatitis B after transplantation operations
18. De novo and apparent de novo hepatitis B virus infection after liver transplantation
19. Fatal hepatitis reactivation after autologous bone marrow transplantation
20. Changing of hepatitis B virus markers in patients with bone marrow transplantation
21. Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: A report of 30 cases
22. Reactivation of hepatitis B virus in two chronic GVHD patients after transplant
23. Hepatitis B reactivation following allogeneic bone marrow transplantation: Case report and review of the literature
24. Hepatitis B infection in Saudi Arabia
25. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
26. Chronic graft-versus-host disease syndrome in man. A long-term clinicopathologic study of 20 Seattle patients
27. Alternating-day cyclosporine and prednisone for treatment of high risk chronic graft-versus-host disease
28. Infection with herpes virus and cell mediated immunity after marrow transplantation
29. Infectious disease during immune recovery after bone marrow transplantation
30. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
31. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen
32. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis
33. Post-transfusion hepatitis: The role of hepatitis B antibody
34. Post-transfusion hepatitis type B following multiple transfusion of HBsAg-negative blood
35. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation
36. Hepatitis B virus immunopathogenesis
37. Hepatitis B virus DNA contains a glucocorticoid-responsive element
38. Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system
39. Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: Evidence of continuing viral suppression with longer duration and higher dose lamivudine therapy
40. Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high grade non-Hodgkin's lymphoma
41. Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation
42. Lamivudine and glycyrrhzin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin's lymphoma
43. Chronic graft-vs-host disease (GVHD) of the liver: Presentation as an acute hepatitis
44. Chronic graft versus host disease in other late complications of bone marrow transplantation
45. Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor
46. Hepatitis virus and hematopoietic cell transplantation: A guide to patient and donor management
47. Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma
48. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors